Norges Bank Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Norges Bank

  • $655 Billion
  • Q2 2024

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$16.93 - $26.41 $10.7 Million - $16.7 Million
-633,780 Closed
0 $0
Q2 2023

Aug 14, 2023
SELL
$12.64 - $24.5 $7.64 Million - $14.8 Million
-604,079 Closed
0 $0
Q3 2022

Nov 13, 2023
BUY
$144.95 - $152.29 $91.9 Million - $96.5 Million
633,780 New
633,780 $95.8 Million
Q2 2022

Aug 14, 2023
BUY
$83.14 - $145.99 $50.2 Million - $88.2 Million
604,079 New
604,079 $88 Million
Q1 2022

May 12, 2023
BUY
$110.08 - $142.92 $53.1 Million - $68.9 Million
482,215 New
482,215 $57.2 Million
Q1 2022

May 09, 2022
SELL
$110.08 - $142.92 $44.3 Million - $57.6 Million
-402,732 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$99.73 - $148.48 $40.2 Million - $59.8 Million
402,732 New
402,732 $55.5 Million
Q3 2021

Nov 14, 2022
BUY
$98.85 - $138.91 $38.8 Million - $54.6 Million
392,909 New
392,909 $54.6 Million
Q3 2021

Nov 05, 2021
SELL
$98.85 - $138.91 $41 Million - $57.6 Million
-414,423 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$65.78 - $105.02 $27.3 Million - $43.5 Million
414,423 New
414,423 $40.2 Million
Q2 2021

Aug 10, 2021
SELL
$65.78 - $105.02 $26.2 Million - $41.8 Million
-397,939 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$64.07 - $91.75 $25.5 Million - $36.5 Million
397,939 New
397,939 $27.2 Million
Q1 2021

May 07, 2021
SELL
$64.07 - $91.75 $32.5 Million - $46.6 Million
-507,638 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$65.07 - $98.24 $33 Million - $49.9 Million
507,638 New
507,638 $43.5 Million
Q4 2020

Feb 10, 2021
SELL
$65.07 - $98.24 $31.8 Million - $48 Million
-488,268 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$59.04 - $77.95 $28.8 Million - $38.1 Million
488,268 New
488,268 $31.7 Million
Q3 2020

Nov 10, 2020
SELL
$59.04 - $77.95 $30.3 Million - $40 Million
-513,505 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$29.01 - $74.23 $14.9 Million - $38.1 Million
513,505 New
513,505 $37.5 Million
Q2 2020

Aug 07, 2020
SELL
$29.01 - $74.23 $14.7 Million - $37.6 Million
-506,370 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$27.51 - $57.29 $13.9 Million - $29 Million
506,370 New
506,370 $17.2 Million
Q1 2020

May 08, 2020
SELL
$27.51 - $57.29 $13.2 Million - $27.5 Million
-480,421 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$40.86 - $57.65 $19.6 Million - $27.7 Million
480,421 New
480,421 $26.2 Million
Q4 2019

Feb 12, 2020
SELL
$40.86 - $57.65 $18.4 Million - $26 Million
-450,803 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$37.38 - $49.47 $16.9 Million - $22.3 Million
450,803 New
450,803 $18.8 Million
Q3 2019

Nov 08, 2019
SELL
$37.38 - $49.47 $16.9 Million - $22.3 Million
-450,803 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$39.79 - $67.01 $17.9 Million - $30.2 Million
450,803 New
450,803 $19.7 Million
Q2 2019

Aug 09, 2019
SELL
$39.79 - $67.01 $4.68 Million - $7.87 Million
-117,510 Closed
0 $0
Q1 2019

May 11, 2020
BUY
$34.52 - $53.29 $4.06 Million - $6.26 Million
117,510 New
117,510 $6.05 Million
Q1 2018

May 09, 2018
SELL
$22.49 - $34.56 $1.12 Million - $1.73 Million
-50,000 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$20.44 - $35.56 $1.02 Million - $1.78 Million
50,000 New
50,000 $1.35 Million
Q4 2017

Feb 09, 2018
SELL
$20.44 - $35.56 $1.02 Million - $1.78 Million
-50,000 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$23.54 - $38.21 $1.18 Million - $1.91 Million
50,000 New
50,000 $1.87 Million
Q3 2017

Nov 07, 2017
SELL
$23.54 - $38.21 $1.18 Million - $1.91 Million
-50,000 Closed
0 $0
Q2 2017

Jul 24, 2018
BUY
N/A
50,000
50,000 $1.25 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email